Brief: Lansen Pharma updates on litigation against Ningbo Liwah unit

Lansen Pharmaceutical Holdings

01/09/2017 15:01

Sept 1 (Reuters) - Lansen Pharma  0503.HK :  
    * Ningbo Liwah received judgment delivered by Shenzhen 
Intermediate People's Court of People's Republic of China 
    * Ningbo Liwah is ordered to pay an amount of about RMB30 
million 
    * Claimant had alleged it suffered certain losses due to use 
of Ginkgo Extract supplied by Ningbo Liwah in claimant's 
products 
 
Source text: (bit.ly/2wsWK6j) 
Further company coverage:  0503.HK  
 
 (bangalore.newsroom@thomsonreuters.com)